Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 10:25 am Sale |
2023-12-31 | 13G | Baudax Bio, Inc. BXRXQ |
BLACK HORSE CAPITAL LP | 0 0.000% |
-500,000 (Position Closed) |
Filing History |
| 2024-02-06 11:12 am Purchase |
2023-12-31 | 13G | Baudax Bio, Inc. BXRXQ |
Mitchell P. Kopin | 814,383 1.800% |
787,291 (+2905.99%) |
Filing History |
| 2023-07-10 5:12 pm Purchase |
2023-06-30 | 13G | Baudax Bio, Inc. BXRXQ |
BLACK HORSE CAPITAL LP | 500,000 6.900% |
500,000 (New Position) |
Filing History |
| 2023-02-14 12:18 pm Purchase |
2022-12-31 | 13G | Baudax Bio, Inc. BXRXQ |
Armistice Capital, LLC | 1,165,709 4.990% |
1,165,709 (New Position) |
Filing History |
| 2023-02-08 06:06 am Purchase |
2022-12-31 | 13G | Baudax Bio, Inc. BXRXQ |
Mitchell P. Kopin | 27,092 5.100% |
27,092 (New Position) |
Filing History |
| 2022-09-06 06:13 am Purchase |
2022-08-29 | 13G | Baudax Bio, Inc. BXRX |
Mitchell P. Kopin | 27,291 6.500% |
16,697 (+157.60%) |
Filing History |
| 2022-05-27 4:03 pm Purchase |
2022-05-17 | 13G | Baudax Bio, Inc. BXRX |
Mitchell P. Kopin | 10,595 4.990% |
9,259 (+692.98%) |
Filing History |
| 2022-02-14 6:41 pm Purchase |
2021-12-31 | 13G | Baudax Bio, Inc. BXRX |
Armistice Capital, LLC | 6,335 9.990% |
3,233 (+104.20%) |
Filing History |
| 2022-01-06 4:03 pm Purchase |
2021-12-27 | 13G | Baudax Bio, Inc. BXRX |
Mitchell P. Kopin | 1,336 2.100% |
1,336 (New Position) |
Filing History |
| 2021-02-16 5:08 pm Purchase |
2020-12-31 | 13G | Baudax Bio, Inc. BXRX |
Armistice Capital, LLC | 3,102 9.990% |
2,460 (+382.84%) |
Filing History |
| 2021-02-16 3:39 pm Sale |
2020-12-31 | 13G | Baudax Bio, Inc. BXRX |
CORSAIR CAPITAL MANAGEMENT LLC | 65 1.000% |
-521 (-88.94%) |
Filing History |
| 2021-02-16 09:43 am Sale |
2020-12-31 | 13G | Baudax Bio, Inc. BXRX |
CVI Investments, Inc. | 0 0.000% |
-769 (Position Closed) |
Filing History |
| 2021-02-12 4:58 pm Sale |
2020-12-31 | 13G | Baudax Bio, Inc. BXRX |
Stonepine Capital Management, LLC | 0 0.000% |
-1,300 (Position Closed) |
Filing History |
| 2021-01-13 09:01 am Sale |
2020-12-31 | 13G | Baudax Bio, Inc. BXRX |
Empery Asset Management, LP | 714 2.600% |
-1,374 (-65.79%) |
Filing History |
| 2021-01-07 11:23 am Sale |
2020-12-31 | 13G | Baudax Bio, Inc. BXRX |
SABBY MANAGEMENT LLC | 0 0.000% |
-744 (Position Closed) |
Filing History |
| 2020-10-30 10:30 am Purchase |
2020-10-28 | 13G | Baudax Bio, Inc. BXRX |
SABBY MANAGEMENT LLC | 744 11.000% |
744 (New Position) |
Filing History |
| 2020-06-09 4:32 pm Sale |
2020-05-31 | 13G | Baudax Bio, Inc. BXRX |
BLACKROCK INC BLK |
349 2.800% |
-18 (-5.02%) |
Filing History |